Sign in

CIK 0001818794 · Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364883909
Phone
(781) 786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 4 Grant or award Chief Financial Officer acquired 66,100 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Planned sale Chief Commercial Officer sold 143 shares at $12.12 ($1,733)
  4. 4 Planned sale SVP, Head of Finance & Admin. sold 1,343 shares at $11.38 ($15,283)
  5. 4 Planned sale Chief Scientific Officer sold 2,153 shares at $11.38 ($24,501)
  6. 4 Planned sale Chief Medical Officer sold 1,343 shares at $11.83 ($15,888)
  7. 4 Planned sale CEO & President sold 4,061 shares at $11.83 ($48,042)
  8. 4 Planned sale SVP, Head of Finance & Admin. sold 917 shares at $11.83 ($10,848)
  9. 4 Planned sale Chief Scientific Officer sold 1,094 shares at $11.83 ($12,942)
  10. 4 Planned sale Chief Scientific Officer sold 2,598 shares at $13.95 ($36,242)
  11. 4 Planned sale SVP, Head of Finance & Admin. sold 2,488 shares at $13.95 ($34,708)
  12. 4 Grant or award Director acquired 1,111,111 shares (grant or award)
  13. 4 Planned sale Chief Scientific Officer sold 2,334 shares at $28.12 ($65,632)
  14. 4 Planned sale SVP, Head of Finance & Admin. sold 1,455 shares at $28.12 ($40,915)
  15. 4 Open-market sale Director sold 136,112 shares at an average $29.30 ($3,988,016)
  16. 4 Grant or award Chief Commercial Officer acquired 37,800 shares (grant or award)
  17. 4 Open-market sale Director sold 138,845 shares at an average $29.38 ($4,079,361)
  18. 4 Grant or award SVP, Head of Finance & Admin. acquired 32,700 shares (grant or award)
  19. 4 Grant or award Chief Medical Officer acquired 48,000 shares (grant or award)
  20. 4 Grant or award CEO & President acquired 145,300 shares (grant or award)

Page 5 of 19 · 361 filings